Norges Bank’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-120,396
| Closed | -$5.98M | – | 1232 |
|
|
2025
Q4 | $5.98M | Buy |
+120,396
| New | +$5.85M | ﹤0.01% | 1359 |
|
|
2025
Q3 | – | Sell |
-31,405
| Closed | -$990K | – | 1372 |
|
|
2025
Q2 | $990K | Sell |
31,405
-39,552
| -56% | -$1.27M | ﹤0.01% | 1547 |
|
|
2025
Q1 | $2.32M | Sell |
70,957
-54,594
| -43% | -$1.93M | ﹤0.01% | 1498 |
|
|
2024
Q4 | $4.54M | Sell |
125,551
-36,779
| -23% | -$1.3M | ﹤0.01% | 1523 |
|
|
2024
Q3 | $5.06M | Sell |
162,330
-46,505
| -22% | -$1.45M | ﹤0.01% | 1527 |
|
|
2024
Q2 | $5.59M | Sell |
208,835
-23,410
| -10% | -$679K | ﹤0.01% | 1532 |
|
|
2024
Q1 | $7.92M | Sell |
232,245
-42,895
| -16% | -$1.28M | ﹤0.01% | 1518 |
|
|
2023
Q4 | $7.96M | Sell |
275,140
-22,148
| -7% | -$587K | ﹤0.01% | 1567 |
|
|
2023
Q3 | $8.2M | Sell |
297,288
-43,359
| -13% | -$1.32M | ﹤0.01% | 1542 |
|
|
2023
Q2 | $10.2M | Sell |
340,647
-16,453
| -5% | -$576K | ﹤0.01% | 1521 |
|
|
2023
Q1 | $12.9M | Sell |
357,100
-71,473
| -17% | -$2.75M | ﹤0.01% | 1474 |
|
|
2022
Q4 | $15.3M | Hold |
428,573
| – | – | ﹤0.01% | 1395 |
|
|
2022
Q3 | $14.5M | Hold |
428,573
| – | – | ﹤0.01% | 1375 |
|
|
2022
Q2 | $12.4M | Sell |
428,573
-46,561
| -10% | -$1.33M | ﹤0.01% | 1457 |
|
|
2022
Q1 | $15.4M | Sell |
475,134
-20,179
| -4% | -$619K | ﹤0.01% | 1521 |
|
|
2021
Q4 | $14.4M | Buy |
495,313
+54,663
| +12% | +$1.66M | ﹤0.01% | 1614 |
|
|
2021
Q3 | $11.8M | Buy |
440,650
+26,887
| +6% | +$722K | ﹤0.01% | 1713 |
|
|
2021
Q2 | $12.7M | Sell |
413,763
-71,916
| -15% | -$2.2M | ﹤0.01% | 1708 |
|
|
2021
Q1 | $12.7M | Sell |
485,679
-45,249
| -9% | -$1.27M | ﹤0.01% | 1717 |
|
|
2020
Q4 | $13.4M | Sell |
530,928
-50,966
| -9% | -$1.1M | ﹤0.01% | 1695 |
|
|
2020
Q3 | $12.1M | Sell |
581,894
-53,226
| -8% | -$1.21M | ﹤0.01% | 1645 |
|
|
2020
Q2 | $15.1M | Sell |
635,120
-63,427
| -9% | -$1.4M | ﹤0.01% | 1593 |
|
|
2020
Q1 | $12.6M | Hold |
698,547
| – | – | ﹤0.01% | 1503 |
|
|
2019
Q4 | $16.6M | Hold |
698,547
| – | – | ﹤0.01% | 1618 |
|
|
2019
Q3 | $19.2M | Sell |
698,547
-31,298
| -4% | -$927K | 0.01% | 1502 |
|
|
2019
Q2 | $24.1M | Hold |
729,845
| – | – | 0.01% | 1384 |
|
|
2019
Q1 | $25.6M | Sell |
729,845
-14,000
| -2% | -$521K | 0.01% | 1334 |
|
|
2018
Q4 | $24.7M | Hold |
743,845
| – | – | 0.01% | 1249 |
|
|
2018
Q3 | $37.5M | Hold |
743,845
| – | – | 0.01% | 1085 |
|
|
2018
Q2 | $44.5M | Buy |
743,845
+81,436
| +12% | +$4.22M | 0.02% | 924 |
|
|
2018
Q1 | $30.3M | Buy |
662,409
+75,818
| +13% | +$3.16M | 0.01% | 1140 |
|
|
2017
Q4 | $23.4M | Buy |
586,591
+185,398
| +46% | +$7.33M | 0.01% | 1370 |
|
|
2017
Q3 | $16M | Buy |
+401,193
| New | +$17.4M | 0.01% | 1558 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
Norges Bank's SUPN Position: Q1 2026 in Review
Norges Bank sold out of Supernus Pharmaceuticals (SUPN) in Q1 2026, closing a stake of 120,396 shares — an estimated $5.98M sold.
Norges Bank first reported a position in SUPN in Q3 2017 and held it in 33 quarters. The position peaked at $44.5M in Q2 2018. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.
- Norges Bank reported no remaining Supernus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Norges Bank sold 120,396 Supernus Pharmaceuticals shares in Q1 2026, an estimated $5.98M.
- Norges Bank first reported a position in Supernus Pharmaceuticals in Q3 2017 and held it in 33 quarters.
- Norges Bank's Supernus Pharmaceuticals position peaked at $44.5M in Q2 2018.
- 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.
Based on Norges Bank's 13F filing for Q1 2026.